Lobbying Relationship

Client

Life Technologies Corporation

More records

Lobbying firm

SIDLEY AUSTIN LLP

More records

  • Policy issues related to regulation of life science research products by FDA

Duration: to

General Issues: Health Issues

Spending: about $170,000 (But it's complicated. Here's why.)

Agencies lobbied since 2012: Food & Drug Administration (FDA)

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Patricia DeLoatche Health Policy Director; Sen. Orrin Hatch Chief of Staff; Rep. Mike Bilirakis Legislative Director; Rep. Mike Bilirakis Legislative Assistant; Rep. Mike Bilirakis Legislative Assistant; Rep. Mike Biliraks Healthy Policy Director; Sen. Orrin Hatch Healthy Policy Director, Sen. Orrin Hatch

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page